Skip to content

The medical device Mindlenses for cognitive rehabilitation in stroke

Comparison of the efficacy of the combination of digital prism adaptation and serious games with standard rehabilitation for cognitive deficits in stroke patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12243194
Enrollment
30
Registered
2024-02-07
Start date
2019-12-05
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive deficits in stroke Mental and Behavioural Disorders

Interventions

Experimental treatment with the medical device Mindlenses, combining prism adaptation with serious games in 10 days. Control treatment with standard cognitive training Patients are randomly assigned

Sponsors

Fondazione Istituto G. Giglio di Cefalù
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. First ever unilateral stroke 2. Aged 30-90 years

Exclusion criteria

Exclusion criteria: 1. Bilateral stroke 2. Other neurological disease

Design outcomes

Primary

MeasureTime frame
All measured at baseline and immediately after the end of treatment: 1. General cognitive functioning will be measured using the Oxford Cognitive Screen 2. General intelligence and abstract thinking will be measured using the Ravens’ Progressive Matrices 3. Verbal short-term and working memory will be assessed using Digit Span Forward and Backward Tests 4. Spatial short-term and working memory will be assessed using Spatial Span Forward and Backward Tests 5. Verbal long-term memory will be assessed using the Rey Auditory Verbal Learning Test, Immediate and Delayed Recall 6. Constructional apraxia will be measured using the Rey Complex Figure Copy, the Freehand Copy of Drawings and The Copy of Drawings with Landmarks Tests 7. Attention will be measured using the Attentive Matrices and The Line Bisection Tests 8. Inhibition abilities will be measured using the Stroop Test 9. Language production abilities will be measured using the Name and Verb Naming Tests 10. Lexical semantic abilities will be measured using the Semantic Fluency Test 11. Visuospatial perception abilities will be measured using the Visual Object and Space Perception Battery (VOSP) 12. Buccofacial apraxia will be measured using the Buccofacial Apraxia Test Removed 13/06/2024: 13. Functional activities of daily living will be measured using the Barthel Index

Secondary

MeasureTime frame
All measured at baseline and immediately after the end of treatment: 1. Anxiety will be measured using the Beck Anxiety Inventory 2. Depression will be measured using the Hamilton Depression Scale Added 13/06/2024: 13. Functional activities of daily living will be measured using the Barthel Index

Countries

Italy

Contacts

Public ContactSergio Bagnato
sergiobagnato@gmail.com+39 (0)921 920111

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 20, 2026